Maria Alessandra Alisi

Author

Angelini Pharma (Italy)ORCID

Also Known As

M. A. ALISI, M. A. Alisi, M.A. Alisi, Maria A. Alisi, Maria Alessandra Alisi, Maria Alessandra Alisi (315412)

Publications

414

Citations

H-Index

Concepts

All Affiliations

Angelini Pharma (Italy)Sapienza University of Rome University of Milan Mediolanum Farmaceutici (Italy)Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

About

Maria Alessandra Alisi is an author at Angelini Pharma (Italy) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	298
2	Biochemistry	8	8	260
3	Natural Sciences	6	6	222
4	Chemical Biology	4	4	131
5	Cell Biology	1	1	51

Maria Alessandra Alisi

Publications

386

Citations

H-Index

Page 1

	Year	Citations
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity Cristina Travelli, Silvio Aprile, Reza Rahimian, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	2017	55
New anti-viral drugs for the treatment of the common cold Caterina Maugeri, Maria Alessandra Alisi, Claudia Apicella, Bioorganic & Medicinal Chemistry Antiviral AgentsMedicineAntiviral Drug DevelopmentAntiviral ResponseAntiviral Therapy	2008	52
Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro Annalisa Bruno, Luigia Di Francesco, Isabella Coletta, Biochemical Pharmacology Medicinal ChemistryNovel InhibitorHuman MonocytesBiochemistryMedicine	2009	51
Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis Federica Finetti, Erika Terzuoli, Isabella Coletta, PLoS ONE	2012	47
Hit Optimization of 5-Substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, Journal of Medicinal Chemistry Novel TreatmentsPharmacotherapySystem PharmacologyChemical BiologyPharmaceutical Chemistry	2015	41
Discovery and Pharmacological Profile of New 1<i>H</i>-Indazole-3-carboxamide and 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands Guido Furlotti, Maria Alessandra Alisi, Claudia Apicella, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistryFunctional Selectivity	2012	40
DPPH radical scavenging activity of paracetamol analogues Maria Alessandra Alisi, Mario Brufani, Nicola Cazzolla, Tetrahedron BiochemistryMedicineRadical (Chemistry)Paracetamol AnaloguesPharmacology	2012	24
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group Cristina Travelli, Silvio Aprile, Daiana Mattoteia, European Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryDrug TargetBiochemistryMedicine	2019	18
Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives Maria Alessandra Alisi, Mario Brufani, Luigi Filocamo, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryBiochemistryNatural SciencesMedicine	1995	17
Targeting Serotonin 2A and Adrenergic α<sub>1</sub> Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐<i>b</i>]indazol‐1(2<i>H</i>)‐one Derivatives Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, ChemMedChem	2018	15

Page 1